VC  Pearl Street Venture Funds

http://www.psvf.com





     Office Locations:

20 North Meridian Street, Suite 805
Indianapolis, IN 46204
Phone: 317-684-3719

Get all office locations for this firm with a National Database subscription.
 

Stages:

  • Early


 

Industries:

  • Food & Agriculture
  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    Pearl Street Venture Funds invests in early stage, Indiana based, life sciences companies in the biotech, medical device, pharmaceutical and agri-bio sectors. The fund seeks therapeutic product companies, 'best of breed' enabling technologies, and technologies that add value to the drug discovery process. Pearl Street Venture Funds expects to make a majority of its investments in early stage venture rounds including initial rounds of funding for corporate spin-outs.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    John H. Barnard Managing Director
    Michael J. Brennan MD, Ph.D. Managing Director
    Stella M. Sung Ph.D. Managing Director
    Timothy J. Tichenor Managing Director

     

    Portfolio companies include:


      Apex Life Sciences
        web link


      BioVigilant
        web link


      Colucid
        web link


      Colucid Pharmaceuticals
        web link


      FlowCo
        web link


      Muroplex Therapeutics
        web link


      Serenex
        web link


     

    Recent News: